In human joints with inflammatory disease, MTX treatment involved A2AR. Adenosine via A2BR prevented MTX-induced inhibition of osteoclast bone destruction in arthritis induced by adjuvant (Teramachi et al., 2011). This evidence concerns the gene ADORA2A and arthritic joint disease.